Alarm bells over Aussie MS stem cell trial

A researcher has raised concerns over the registration of an Australian MS stem cell trial that has not demonstrated efficacy from preclinical studies.

The trial, which was registered by the Australian New Zealand Clinical Trials Registry in early July, aims to evaluate the efficacy and safety of treatments using autologous stem cells, platelet-rich-plasma and peptides on patients with MS.

It will